Acarbose is an anti-diabetic medication that is used to treat type 2 diabetes and, in some countries, prediabetes.
The global market size of Acarbose in terms of volume is 65.40 metric tonnes.
There are 23 suppliers across the globe who manufacture Acarbose API.
The report provides critical information on the state of the industry and serves as a valuable resource for companies and individuals interested in the market.
The innovator and the developer is Bayer ag of the Acarbose API.It is marketed as Glucobay (Bayer AG) in Europe and China, Precose (Bayer Pharmaceuticals) in North America, and Prandase in Canada (Bayer AG).
It is inexpensive and widely used in China, but not in the United States.
According to one physician, the drug’s use in the United States is limited since it isn’t powerful enough to warrant the unpleasant side effects of diarrhea and flatulence.
However, “acarbose is efficacious, safe, and well-tolerated in a large cohort of Asian individuals with type 2 diabetes,” according to recent major research.